Publications by authors named "Takako Onodera"
BMC Womens Health
August 2021
Article Synopsis
- Relugolix, an oral medication for treating leiomyoma, has shown potential effectiveness based on a phase 3 study, but its impact on severe adenomyosis is under-researched.
- A case study of a 49-year-old woman with both leiomyomas and adenomyosis indicates that relugolix treatment led to significant uterine shrinkage and symptom relief, allowing her to avoid surgery.
- The case suggests that combining relugolix with a traditional Japanese remedy, kamishoyosan, may help alleviate side effects like hot flushes and headaches, highlighting a new approach to managing co-occurring conditions.
